Addtech acquires a Finnish diagnostics company
(Thomson Reuters ONE) -
Addtech Life Science, a business area in the Addtech Group, has today signed an
agreement to acquire all shares outstanding in Immuno Diagnostic Oy.
Immuno Diagnostic Oy sells diagnostic and research reagents to hospital
laboratories, medical schools, universities and to the pharmaceutical industry.
The company has a strong position on the Finnish market and represents leading
suppliers in the field of immunology and molecular biology. The company has ten
employees and revenue of approximately EUR 4 million.
Immuno Diagnostic Oy constitutes an excellent compliment to Addtech's operations
within the business unit Diagnostics. This business unit focuses on sales of
reagents and equipment for hospital laboratories in the entire Nordic Region.
The closing will be on the 31 of May 2010 and the acquisition is estimated to
have a marginally positive effect on Addtech's earnings per share during the
current financial year.
Stockholm, 7 May 2010
Addtech AB (publ)
For further information, contact
Johan Sjö, President, Addtech AB, +46 8 470 49 00
Göran Brandt, Business area manager, Addtech Life Science, +46 8 59 41 13 55
[HUG#1413146]
Addtech acquires a Finnish diagnostics company: http://hugin.info/132861/R/1413146/365242.pdf
Unternehmensinformation / Kurzprofil:
Datum: 07.05.2010 - 13:31 Uhr
Sprache: Deutsch
News-ID 20500
Anzahl Zeichen: 0
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 206 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Addtech acquires a Finnish diagnostics company"
steht unter der journalistisch-redaktionellen Verantwortung von
Addtech AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
